DA
DVAX

Denali Advisors’s Dynavax Technologies DVAX Stock Holding History

Denali Advisors’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-77,300
Closed -$999K – 489
2023
Q2 		$999K Buy
77,300
+64,500
+504% +$735K 0.35% 76
2023
Q1 		$126K Buy
+12,800
New +$137K 0.05% 162

Other funds holding DVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Denali Advisors's DVAX Position: Q3 2023 in Review

Denali Advisors sold out of Dynavax Technologies (DVAX) in Q3 2023, closing a stake of 77,300 shares — an estimated $999K sold.

Denali Advisors first reported a position in DVAX in Q1 2023 and held it in 2 quarters. The position peaked at $999K in Q2 2023. 225 funds tracked by Wall St. Rank hold DVAX as of Q3 2023.

  • Denali Advisors reported no remaining Dynavax Technologies position as of Q3 2023 after selling out during the quarter.
  • Denali Advisors sold 77,300 Dynavax Technologies shares in Q3 2023, an estimated $999K.
  • Denali Advisors first reported a position in Dynavax Technologies in Q1 2023 and held it in 2 quarters.
  • Denali Advisors's Dynavax Technologies position peaked at $999K in Q2 2023.
  • 225 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2023.

Based on Denali Advisors's 13F filing for Q3 2023, filed 19 Oct 2023.